Legal Status
Legal Status
Notice
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Focus Groups as Used by the Food and Drug Administration
A Notice by the Food and Drug Administration on
Document Details
Information about this document as published in the Federal Register.
- Printed version:
- Publication Date:
- 02/27/2006
- Agencies:
- Food and Drug Administration
- Dates:
- Fax written comments on the collection of information by March 29, 2006.
- Comments Close:
- 03/29/2006
- Document Type:
- Notice
- Document Citation:
- 71 FR 9828
- Page:
- 9828-9829 (2 pages)
- Agency/Docket Number:
- Docket No. 2005N-0443
- Document Number:
- E6-2726
Document Details
-
Enhanced Content - Table of Contents
This tables of contents is a navigational tool, processed from the headings within the legal text of Federal Register documents. This repetition of headings to form internal navigation links has no substantive legal effect.
Enhanced Content - Table of Contents
-
Enhanced Content - Submit Public Comment
- This feature is not available for this document.
Enhanced Content - Submit Public Comment
-
Enhanced Content - Read Public Comments
Enhanced Content - Read Public Comments
-
Enhanced Content - Sharing
- Shorter Document URL
- https://www.federalregister.gov/d/E6-2726 https://www.federalregister.gov/d/E6-2726
Enhanced Content - Sharing
-
Enhanced Content - Document Tools
These tools are designed to help you understand the official document better and aid in comparing the online edition to the print edition.
-
These markup elements allow the user to see how the document follows the Document Drafting Handbook that agencies use to create their documents. These can be useful for better understanding how a document is structured but are not part of the published document itself.
Display Non-Printed Markup Elements
Enhanced Content - Document Tools
-
-
Enhanced Content - Developer Tools
This document is available in the following developer friendly formats:
- JSON: Normalized attributes and metadata
- XML: Original full text XML
- MODS: Government Publishing Office metadata
More information and documentation can be found in our developer tools pages.
Enhanced Content - Developer Tools
Published Document
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
DATES:
Fax written comments on the collection of information by March 29, 2006.
ADDRESSES:
OMB is still experiencing significant delays in the regular mail, including first class and express mail, and messenger deliveries are not being accepted. To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: Fumie Yokota, Desk Officer for FDA, FAX: 202-395-6974.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of Management Programs (HFA-250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4659.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance.
Focus Groups as Used by the Food and Drug Administration—(OMB Control Number 0910-0497)—Extension
FDA will collect and use information gathered through the focus group vehicle. This information will be used to develop programmatic proposals, and as such, compliments other important research findings to develop these proposals. Focus groups do provide an important role in gathering information because they allow for a more in-depth understanding of consumers' attitudes, beliefs, motivations, and feelings than do quantitative studies.
Also, information from these focus groups will be used to develop policy and redirect resources, when necessary, to our constituents. If this information is not collected, a vital link in information gathering by FDA to develop policy and programmatic proposals will be missed causing further delays in policy and program development.
In the Federal Register of November 25, 2005 (FR 70 71165), FDA published a 60-day notice requesting public comment on the information collection provisions. FDA received one comment, however it was not related to the information collection.
Annually, FDA projects about 28 focus group studies using 286 focus groups lasting an average of 1.78 hours each. FDA has allowed burden for unplanned focus groups to be completed so as not to restrict the agency's ability to gather information on public sentiment for its proposals in its regulatory as well as other programs. To arrive at each center's estimated burden we multiplied the number of focus groups per study by the number of participants per group. (e.g., Center for Biologics Evaluation and Research (CBER): 5x9=45). We multiplied that total by the hours of duration for each group to arrive at the total burden hours. (e.g., CBER: 45x1.58=71.1).
The total annual estimated burden imposed by this collection of information is 4,252 hours annually.
FDA estimates the burden of this collection of information as follows:
FDA Center | Subject | No. of Focus Groups per Study | No. of Focus Groups Sessions Conducted Annually | No. of Participants per Group | Hours of Duration for Each Group (Includes Screening) | Total Hours |
---|---|---|---|---|---|---|
Center for Biologics Evaluation and Research | May use focus groups when appropriate | 1 | 5 | 9 | 1.58 | 71 |
Center for Drug Evaluation and Research | Varies (e.g., direct-to-consumer Rx drug promotion, physician labeling of Rx drugs, medication guides, over-the-counter drug labeling, risk communication) | 10 | 200 | 9 | 1.58 | 2,844 |
Center for Devices and Radiological Health | Varies (e.g., FDA Seal of Approval, patient labeling, tampons, on-line sales of medical products, latex gloves) | 4 | 16 | 9 | 2.08 | 300 |
Center for Food Safety and Applied Nutrition | Varies (e.g., food safety, nutrition, dietary supplements, and consumer education) | 8 | 40 | 9 | 1.58 | 569 |
Center for Veterinary Medicine | Varies (e.g., animal nutrition, supplements, labeling of animal Rx) | 5 | 25 | 9 | 2.08 | 468 |
Start Printed Page 9829 | ||||||
Total | 28 | 286 | 1.78 | 4,252 | ||
1 There are no capital costs or operating and maintenance costs associated with this collection of information. |
Dated: February 21, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6-2726 Filed 2-24-06; 8:45 am]
BILLING CODE 4160-01-S